Valuation Methods for Pharma and Biotech Firms: Creating Financial Models that Attract Investors
The pharmaceutical and biotechnology industries bring unique opportunities for high returns and considerable risks. Traditional valuation methods often fall short due to the uncertainties of drug development, regulatory hurdles, and extended timelines before profitability. Accurately valuing firms is vital for attracting investors, securing funding, and ensuring long-term sustainability. We have also built a ready-to-go Pharma […]